Conditions · Alzheimer's disease & early-stage dementia
Alzheimer's disease & early-stage dementia — frontier options in Maryland
20 open options
- TRIALPHASE3RECRUITING
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Xanomeline/Trospium Chloride Capsule · Xanomeline Enteric Capsule · Placebo — 159 sites
- TRIALNARECRUITING
Working Memory and Physical Exercise Training in Patients With Mild Cognitive Impairment
Progressive aerobic exercise · Adaptive cognitive training · Combined — 1 site
- TRIALEARLY_PHASE1RECRUITING
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Psilocybin — 1 site
- TRIALNANOT_YET_RECRUITING
Fall Prevention in Mild Cognitive Impairment
Virtual Neurophysiological Rehabilitation — 1 site
- TRIALNARECRUITING
e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most
e-ALIGN Patient-Portal Deprescribing — 1 site
- TRIALNARECRUITING
Vestibular Therapy in Alzheimer's Disease
Vestibular physical therapy · Active control — 1 site
- TRIALPHASE2NOT_YET_RECRUITING
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Psilocybin · Cognitive Training — 1 site
- TRIALNANOT_YET_RECRUITING
Personalized Closed-Loop Brain Stimulation for Patients With Mild Cognitive Impairment
Active tES · Cognitive Interventions — 1 site
- TRIALPHASE1RECRUITING
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
18F-PF974 · 18F-florbetaben — 1 site
- TRIALPHASE2RECRUITING
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
LHP588 · LHP588 · Placebo Drug — 40 sites
- TRIALNARECRUITING
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
Trier Social Stress Test — 1 site
- TRIALPHASE2RECRUITING
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
Atorvastatin Oral Tablet — 1 site
- TRIALPHASE3RECRUITING
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Acoramidis · Placebo oral tablet — 104 sites
- TRIALNARECRUITING
HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
HEARS-NPS device · HEARS-NPS program — 1 site
- TRIALPHASE2RECRUITING
Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
Trazodone · Placebo — 1 site
- TRIALPHASE1RECRUITING
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
11C-MC1 · 11C-PS13 · 18f-florbetaben — 1 site
- TRIALNARECRUITING
Music Therapy for Patients With Alzheimer's Disease
Virtual Music Therapy — 1 site
- TRIALPHASE3RECRUITING
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
KarXT · KarX-EC — 256 sites
- TRIALPHASE2RECRUITING
Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
CORT108297 · Placebo — 1 site
- TRIALPHASE2RECRUITING
Clinical Trial on Agitation in Alzheimer's Dementia
IGC-AD1-Active · IGC-AD1-Placebo — 31 sites
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.